3.49% -0.0271

Scynexis Inc (SCYX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SCYX? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Scynexis Inc Stock (SCYX) Company Profile

Scynexis Inc

Healthcare (1111)

201-884-5485

1 EVERTRUST PLAZA, JERSEY CITY, NJ

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SCYX's Discussions on Twitter

Compare SCYX vs TAK, ZTS, HLN, TEVA, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SCYX Scynexis Inc	0.75	32.61M	2.93M	-25.30M	-33.59M	-0.5363
TAK Takeda Pharmaceutical Co Adr	18.46	58.03B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	126.65	55.37B	9.40B	2.65B	2.24B	5.935
HLN Haleon Plc Adr	11.20	49.70B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	33.98	39.50B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	473.66	20.50B	3.13B	1.27B	1.12B	26.39

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-01-22	Eingeleitet	Guggenheim	Buy
2021-01-06	Eingeleitet	Cantor Fitzgerald	Overweight
2018-07-11	Hochstufung	Needham	Hold → Buy
2018-06-27	Eingeleitet	Maxim Group	Buy
2017-10-24	Eingeleitet	Guggenheim	Buy
2017-07-10	Eingeleitet	ROTH Capital	Buy
2017-05-09	Herabstufung	Needham	Buy → Hold
2017-03-03	Bestätigt	RBC Capital Mkts	Outperform
2016-10-20	Eingeleitet	H.C. Wainwright	Buy
2016-10-07	Hochstufung	WBB Securities	Buy → Strong Buy
2016-10-03	Fortgesetzt	Brean Capital	Buy
2016-08-17	Eingeleitet	Guggenheim	Buy
2016-08-09	Bestätigt	Needham	Buy
2016-08-09	Hochstufung	WBB Securities	Speculative Buy → Buy
2016-03-28	Eingeleitet	Brean Capital	Buy
2015-12-29	Eingeleitet	WBB Securities	Speculative Buy
2015-11-16	Bestätigt	RBC Capital Mkts	Outperform
2015-06-10	Eingeleitet	Needham	Buy
2014-05-29	Eingeleitet	Canaccord Genuity	Buy
2014-05-29	Eingeleitet	RBC Capital Mkts	Outperform

Alle ansehen

Scynexis Inc Aktie (SCYX) Neueste Nachrichten

Finanzdaten der Scynexis Inc-Aktie (SCYX)

Scynexis Inc (SCYX)

Scynexis Inc Stock (SCYX) Company Profile

Compare SCYX vs TAK, ZTS, HLN, TEVA, UTHR

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

Scynexis Inc Aktie (SCYX) Neueste Nachrichten

Market Moves: Is SCYNEXIS Inc backed by strong institutional buyingQuarterly Portfolio Report & AI Forecast Swing Trade Picks - baoquankhu1.vn

Invasive Fungal Infections Market to Witness Upsurge in Growth at a CAGR of 11.4% (in the US) During the Forecast Period (2025-2034) | DelveInsight - The AI Journal

FOMO Trade: Does SCYNEXIS Inc have pricing powerJuly 2025 Levels & Community Driven Trade Alerts - baoquankhu1.vn

Swing Trade: Is SCYNEXIS Inc backed by strong institutional buyingMarket Performance Summary & Weekly Consistent Profit Watchlists - baoquankhu1.vn

SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting - marketscreener.com

Scynexis (SCYX) to Present Data on Advanced Antifungal Drug at K - GuruFocus

SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) - The Manila Times

New antifungal SCY-247 shows potent activity against deadly drug-resistant fungi - stocktitan.net

Companies Like SCYNEXIS (NASDAQ:SCYX) Could Be Quite Risky - Sahm

Aug Macro: Can SCYNEXIS Inc expand into new marketsQuarterly Earnings Summary & Safe Entry Trade Reports - baoquankhu1.vn

JERSEY CITYFDA grants fast track and QIDP designations to SCYNEXIS drug - Investing.com Nigeria

Scynexis (SCYX) Gains FDA Designations for Antifungal Therapy SC - GuruFocus

Scynexis receives FDA qualified infectious disease product and fast track designations for SCY-247 - marketscreener.com

SCYNEXIS Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247 - The Manila Times

FDA fast-tracks new antifungal aimed at deadly Candida auris infections - Stock Titan

Breakout Move: Is SCYNEXIS Inc benefiting from innovation trendsMarket Sentiment Review & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Aug Volume: Is SCYNEXIS Inc stock trending bullishWeekly Trade Analysis & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn

FEDERATED HERMES, INC. Acquires Additional Shares in SCYNEXIS Inc. - GuruFocus

Retail Trends: Can SCYNEXIS Inc expand into new marketsWeekly Gains Report & Short-Term Swing Trade Alerts - baoquankhu1.vn

RSI Check: Is SCYNEXIS Inc benefiting from innovation trendsWeekly Trend Report & AI Based Buy/Sell Signal Reports - baoquankhu1.vn

Jobs Data: Will SCYNEXIS Inc stock continue dividend increasesJuly 2025 Levels & Community Driven Trade Alerts - Bộ Nội Vụ

Published on: 2026-01-11 17:42:44 - Улправда

SCYNEXIS halts phase 3 MARIO trial, raising new questions for ibrexafungerp’s growth path - MSN

Why SCYNEXIS Inc. (135A) stock is listed among top recommendationsJobs Report & Low Risk Investment Opportunities - ulpravda.ru

Why hedge funds are buying SCYNEXIS Inc. stockWeekly Trade Summary & AI Driven Price Predictions - Улправда

Gains Report: Does SCYNEXIS Inc stock trade at a discount to peersWeekly Trade Recap & Expert Curated Trade Ideas - Bộ Nội Vụ

How SCYNEXIS Inc. stock compares to industry benchmarksOptions Play & Daily Stock Momentum Reports - Улправда

Why SCYNEXIS Inc. stock is trending among retail tradersResistance Breakout Alerts & Free Rapid Return Acceleration - bollywoodhelpline.com

Portfolio Update: How SCYNEXIS Inc stock compares to industry benchmarksJuly 2025 Highlights & Free Safe Capital Growth Stock Tips - moha.gov.vn

SCYNEXIS granted Nasdaq extension to regain bid price compliance - MSN

What analysts say about SCYNEXIS Inc 135A stockFundamental Strength Indicators & Build Wealth With Expert Timing Advice - earlytimes.in

Scynexis receives 180-day extension from Nasdaq to meet listing requirements - Investing.com

Scynexis granted 180-day extension by Nasdaq to regain compliance with minimum bid price requirement - marketscreener.com

SCYNEXIS, Inc. Receives 180-Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Quiver Quantitative

SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - The Manila Times

Earnings Report: Why SCYNEXIS Inc. stock is trending among retail tradersAnalyst Downgrade & Long Hold Capital Preservation Plans - Улправда

SCYNEXIS Earnings Notes - Trefis

Is SCYNEXIS Inc. stock trading at a premium valuationEarnings Risk Summary & Reliable Volume Spike Alerts - Улправда

Shorts Report: How SCYNEXIS Inc. (135A) stock compares with tech leadersEarnings Summary Report & Safe Entry Momentum Stock Tips - moha.gov.vn

SCYNEXIS Halts Phase 3 MARIO Trial, Raising New Questions for Ibrexafungerp’s Growth Path - TipRanks

Will SCYNEXIS Inc. stock deliver better than expected guidance2025 Key Lessons & Advanced Swing Trade Entry Plans - DonanımHaber

Can SCYNEXIS Inc. stock continue upward trendEarnings Summary Report & Long-Term Growth Stock Strategies - Улправда

How SCYNEXIS Inc. (135A) stock compares with tech leadersJuly 2025 Momentum & Verified Stock Trade Ideas - Bölüm Sonu Canavarı

Why SCYNEXIS Inc. stock is a must watch in 2025Market Trend Review & Fast Momentum Stock Entry Tips - Улправда

Nasdaq Moves: Why SCYNEXIS Inc. stock is a must watch in 2025Weekly Stock Recap & AI Powered Market Trend Analysis - Улправда

Is SCYNEXIS Inc. stock a contrarian buy2025 Trading Volume Trends & AI Powered Buy and Sell Recommendations - ulpravda.ru

What insider purchases suggest about SCYNEXIS Inc. (135A) stockJuly 2025 Macro Moves & AI Enhanced Trading Alerts - ulpravda.ru

Revenue per share of SCYNEXIS, Inc. – BER:135A - TradingView — Track All Markets

SCYNEXIS (NASDAQ:SCYX) versus NewAmsterdam Pharma (NASDAQ:NAMS) Head to Head Analysis - Defense World

Finanzdaten der Scynexis Inc-Aktie (SCYX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SCYX